Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed And/or Refractory Follicular Lymphoma after ≥2 Prior Therapies Including Those with a History of POD24: 4-Year Follow-up of a Pivotal Phase II Study

Mazyar Shadman,Nancy L. Bartlett,Matthew Matasar,Stephen J. Schuster,Sarit E. Assouline,Laurie H. Sehn,John Kuruvilla,Pratyush Giri,Chan Y. Cheah,Sascha Dietrich,Keith Fay,Matthew Ku,Loretta Nastoupil,Michael C. Wei,Shen Yin,Connie Y. Ma,Samuel Tracy,Antonia Kwan,Elicia Penuel,L. Elizabeth Budde

Blood（2024）

Cited 0|Views2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined